Prinsen Larisse
Department of Public Law, University of the Free State, Bloemfontein, South Africa.
Front Genet. 2024 Apr 3;15:1272924. doi: 10.3389/fgene.2024.1272924. eCollection 2024.
Biomedical research using human biological material and data is essential for improving human health, but it requires the active participation of many human volunteers in addition to the distribution of data. As a result, it has raised numerous vexing questions related to trust, privacy and consent. Trust is essential in biomedical research as it relates directly to the willingness of participants to continue participating in research. Privacy and the protection of personal information also influence trust. Informed consent has proven to be insufficient as it cannot overcome the informational deficit between primary and unknown future uses of material and data and is therefore not fully informed and invalid. Broad consent is also problematic as it takes full control of samples and data flow from the research participant and inherently requires that a participant must trust that the researcher will use their material or data in a manner that they would find acceptable. This paper attempts to offer some insight into how these related issues can be overcome. It introduces dynamic consent as a consent model in research involving human biological material and its associated data. Dynamic consent is explained, as well as its claims of superiority in instances where future research is possible. It is also shown how dynamic consent contributes to better control of the samples and data by the research participant, and how trust may be improved by using this consent model. Dynamic consent's co-existence with and support of the South African Protection of Personal Information Act of 2013 is also assessed. The limitations of dynamic consent are also discussed.
使用人类生物材料和数据进行生物医学研究对于改善人类健康至关重要,但除了数据分发外,还需要许多人类志愿者的积极参与。因此,它引发了许多与信任、隐私和同意相关的棘手问题。信任在生物医学研究中至关重要,因为它直接关系到参与者继续参与研究的意愿。隐私和个人信息保护也会影响信任。事实证明,知情同意是不够的,因为它无法克服生物材料和数据最初使用与未来未知使用之间的信息差距,因此并非完全知情且无效。广泛同意也存在问题,因为它完全控制了研究参与者的样本和数据流,并且本质上要求参与者必须相信研究人员会以他们认为可接受的方式使用他们的材料或数据。本文试图对如何克服这些相关问题提供一些见解。它引入了动态同意作为涉及人类生物材料及其相关数据的研究中的一种同意模式。文中解释了动态同意及其在未来可能进行研究的情况下的优势主张。还展示了动态同意如何有助于研究参与者更好地控制样本和数据,以及使用这种同意模式如何可能改善信任。同时还评估了动态同意与2013年《南非个人信息保护法》的共存及对该法的支持情况。文中也讨论了动态同意的局限性。